Analyst Insights: Steven Madden, Kraft, VIVUS, Gap, Westport Innovations April 30th

Steven Madden, Ltd. (NASDAQ:SHOO): Sterne Agee believes that Steve Madden has multiple positive catalysts and the firm thinks that the company’s EPS and margins will surpass expectations. The firm maintains a $47 target and Buy rating on the shares.

Kraft Foods Inc. (NYSE:KFT): Credit Suisse recommends buying Kraft Foods ahead of Thursday’s earnings report. The firm believes Kraft will benefit from falling chocolate and coffee costs. Shares are Outperform rating and $45 price target.

VIVUS Inc. (NASDAQ:VVUS): After the FDA approved VIVUS’ erectile dysfunction drug, Stendra, JMP Securities expects the company to find a profitable partner for the drug, or sell it. The firm thinks the company could obtain about $3 per share for the treatment, and it maintains a $45 target and reiterates an Outperform rating on the stock.

Gap Inc. (NYSE:GPS): Susquehanna raised its price target on Gap as they believe the company is in the early stages of reinvigorating its brand recognition. The firm also cited the company’s strong spring season results and improvements in merchandising and marketing. Shares are Positive rated.

Westport Innovations Inc. (NASDAQ:WPRT): Westport Innovations weakness is a buying opportunity, says Craig-Hallum

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.